Loading data for BAX — first visit, this takes a few seconds.

알림

Baxter International Inc. (BAX)

NYSE: BAX · 실시간 가격 · USD

25.94

+0.03 (0.12%)

종가 기준: Aug 18, 2026, 8:00 PM

0.12% (1D)

데이터 없음

매수호가	25.85
시가총액	13.41B
매출 (ttm)	11.47B
순이익 (ttm)	-968M
베타	0.59
EPS (ttm)	-1.88
P/E (ttm)	n/a
선행 P/E	12.74
P/B (ttm)	2.16
P/S (ttm)	1.17
Earnings Date	Oct 29, 2026

매도호가	26.89
거래량	6,671,572
평균 거래량 (20일)	7,031,929
시가	26.08
전일 종가	25.91
일중 범위	25.75 - 26.34
52주 범위	15.73 - 30.00
애널리스트	n/a
목표주가	n/a
배당	$0.04 (0.15%)
배당락일	2026년 8월 28일

BAX 소개

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant produ...

[더 보기]

산업 Medical Instruments & Supplies

섹터 Healthcare

IPO 일자 Oct 27, 1981

직원 수 37,500

상장 거래소 NYSE

티커 BAX

웹사이트 https://www.baxter.com

전체 기업 정보

재무 실적

2025년 Baxter International의 매출은 11.24B로, 전년 10.64B 대비 5.72% 증가했습니다. 순이익은 -957M로, 47.46% 증가했습니다.

재무제표

어닝 서프라이즈

Baxter International가 Jul 30, 2026에 분기 실적을 발표했습니다:

매출 $2.96B 예상치 하회 $0, 및 5.34% 전년 대비 성장.

EPS 0.56 예상치 상회 0.19, 및 -5.08% 전년 대비 감소.

다음 실적 발표

Baxter International Inc.의 실적 발표 예정일은 Oct 29, 2026, 장 시작 전입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

3일 전 · StockStory

3 Stocks Under $50 with Questionable Fundamentals

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune t...

4일 전 · Zacks

WST Stock Surges 38.1% Since March-End: What's Fueling the Rally?

West Pharmaceutical Services has surged 38.1% since March-end as HVP demand, GLP-1 growth and productivity gains fuel the rally.

6일 전 · Zacks

Omnicell Raises 2026 EPS Outlook as Memory Costs Pressure Margins

OMCL raised its 2026 EPS outlook after a strong second quarter, but rising memory-chip costs and delayed hospital purchases could test margins.

1주 전 · Simply Wall St.

Does Cardinal Health’s New CAO and Recalls Reveal Shifts in Its Risk Profile and Earnings Quality (CAH)?

In early August 2026, Cardinal Health announced that Anita Zielinski will become Chief Accounting Officer in November, following her interim CFO and senior accounting roles at Baxter and long tenure a...

2주 전 · Simply Wall St.

Baxter (BAX) Stock Gets Fair Value Boost After Q2 Beat And Higher Targets

Baxter International is back in focus after the fair value estimate in one widely used model moved from US$21.54 to US$27.29, a change of about 27% that feeds directly into updated price target discus...

2 페이지 중 1

Baxter International Inc. (BAX)